Shire PLC (NASDAQ:SHPG)

257.66
Data as of Sep 12
 +0.50 / +0.19%
Today’s Change
113.59
Today|||52-Week Range
258.55
+82.36%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$50.6B

Company Description

Shire Plc is a biopharmaceutical company that focuses on meeting the needs of physicians. It focuses its business on attention deficit hyperactivity disorder, human genetic therapies and gastrointestinal diseases, as well as opportunities in other therapeutic areas. It operates under three segments which include Specialty Pharma, Human Genetic Therapies and Regenerative Medicine. The Specialty Pharmaceuticals segment focuses on small-molecule medications, including Vyvanse for the treatment of attention deficit hyperactivity disorder in children aged 6 to 17, FOSRENOL for the treatment of chronic kidney disease in pre-dialysis patients, XAGRID for the treatment of essential thrombocythaemia, JUVISTA for the improvement of scar appearance, LIALDA/MEZAVANT for the treatment of diverticulitis and RESOLOR for the treatment of chronic constipation in males. The Human Genetic Therapies segment offers products, including FIRAZYR for the treatment of acute hereditary angioedema, REPLAGAL for fabry disease and HGT-2310 for the treatment of Hunter syndrome with central nervous system symptoms, idursulfase-intrathecal delivery. The Regenerative Medicine segment focuses on Dermagraft, a bioengineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process. The company was founded in 1986 and is headquartered in Dublin, Ireland.

Contact Information

Shire Plc
5 Riverwalk
Dublin -- 24
P:(531) 429-7700
Investor Relations:
(531) 482-0999

Employees

Shareholders

Other institutional9.99%
Mutual fund holders5.12%
Individual stakeholders--

Top Executives

Flemming ├śrnskovChief Executive Officer & Director
James BowlingChief Financial Officer, Senior VP & Controller
Philip J. VickersHead-Research & Development
Mario SaltarelliSenior VP-Clinical Development & Medical Affairs
Mark J. EnyedySenior VP & Head-Internal Medicine Business

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.